https://endpts.com/in-latest-setback-for-solid-tumor-car-t-celyad-pauses-trial-following-two-patient-deaths/
The safety that CHM has shown so far in its fight against solid tumour shouldn't be taken for granted. And 75% stable disease at low dose is pretty impressive too.
All that for 16c on market. Or pay 17c and get a free option.
Its not often that periods of opportunity like this present themselves. Still a bit of a wait. But its going to be z very cool ride with this pipeline.
Ann: 2nd dose cohort in CLTX CAR T (supplementary announcement), page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $31.98K | 7.997M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2764810 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 18629873 | 23 |
View Market Depth
| Last trade - 12.22pm 25/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |